A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension



Status:Completed
Conditions:High Blood Pressure (Hypertension), Ocular
Therapuetic Areas:Cardiology / Vascular Diseases, Ophthalmology
Healthy:No
Age Range:40 - Any
Updated:1/1/2014
Start Date:June 2013
End Date:March 2014
Contact:Allergan Inc.
Email:clinicaltrials@allergan.com

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

This is a safety and efficacy study of fixed-combination bimatoprost and brimonidine
compared with LUMIGAN® and ALPHAGAN® in patients with chronic glaucoma or ocular
hypertension.


Inclusion Criteria:

- Diagnosis of ocular hypertension or glaucoma

- Requires intraocular pressure (IOP)-lowering therapy

Exclusion Criteria:

- Cataract surgery in one eye

- Ocular laser or intraocular surgery within 6 months

- Refractive surgery in either eye

- Anticipated use of contact lenses during the study

- Expected use of artificial tears during the study
We found this trial at
1
site
Clinical Trial Facility in Newport Beach California
Newport Beach, California 92660
?
mi
from
Newport Beach, CA
Click here to add this to my saved trials